Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 797

Nav nabs series C funding

Goldman Sachs has led the business financial management platform's $44.8m series C round, which included existing investors Experian and CreditEase's corporate venturing units.

Feb 12, 2019

Siegel seeks out board position at Illumina

GE’s chief innovation officer and GE Ventures’ CEO, Sue Siegel, has been appointed by Illumina to sit on its board of directors.

Feb 12, 2019

Hinge completes Match union

Match Group, which acquired a 51% stake in CAA-backed dating app Hinge last summer, has purchased the remaining shares in the business.

Feb 12, 2019

NuVera veers toward $15m

The General Electric-backed medical device developer has reached a first close of a $15m round that was led by Cormorant and backed by Lilly Asia Ventures.

Feb 12, 2019

UL takes a risk on KenSci in $22m round

UL Ventures' parent company will offer assistance in growth and compliance to the healthcare risk assessment platform developer, which has just raised series B funding.

Feb 12, 2019

KenSci foretells $22m series B

The UW-founded healthcare forecasting software developer has collected $30.5m in all from backers including OUP and a unit of compliance firm UL.

Feb 12, 2019

Arkansas opens Gap Fund

The fund has an annual budget of $400,000 and will complement two other schemes under the university Chancellor’s Fund for Innovation and Collaboration.

Feb 12, 2019

IU commences dig at the Quarry

Indiana University has retooled its entrepreneurial support offering to enhance its services in business case development, executive recruitment and the sourcing of capital.

Feb 12, 2019

SoftBank Vision Fund delivers $940m to Nuro

Nuro has already begun trialling its self-driving delivery vehicle and will use the funding to move into new cities and further develop the technology.

Feb 11, 2019

Harpoon snags public markets listing

The Taiho and Eli Lilly-backed immunotherapy developer floated in the middle of its range to raise $75.6m, valuing it at about $334m.

Feb 11, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here